6th Annual Advances in Chemical Sciences Symposium
May 8, 2017
CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award
November 26, 2018
Our Alumni, Frequency Therapeutics, Announces $32 Million Series A Investment. Congratulations!
May 23, 2017
Congratulations to our alumni, Frequency Therapeutics team with this great achievement!
The funding of $32 million Series A will support their clinical development and research for hearing restoration therapeutic. We wish you all the best in your future endeavors.
Frequency Therapeutics,a company developing a pipeline of new drugs that activate progenitor cells within the body, today announced the closing of a $32 million Series A financing. The funding round was led by CoBro Ventures. Additional participating investors included Morningside Ventures, Emigrant Capital Corp., Korean Investment Partnership, Alexandria Real Estate Equities and other U.S. and international investors.